ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 810
    Damage Assessment in Takyasu Arteritis Using Takayasu Arteritis Damage Score (TADS)
  • Abstract Number: 25
    DC-STAMP Modulates Osteoblast Differentiation and Regulates Bone Repair
  • Abstract Number: 341
    Death Receptor 3 Causes Vascular Dysfunction in a Murine Model of Rheumatoid Arthritis
  • Abstract Number: 43
    Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009
  • Abstract Number: 2506
    Decrease in the Number of Peripheral Leukocytes and Neutrophils and Increase of the Percentage of Eosinophils at 4 Week Predict the DAS28-ESR Remission at 24 Weeks after Administration of Tocilizumab
  • Abstract Number: 2207
    Decreased Bone Mineral Density in Patients with Ehler-Danlos Syndrome
  • Abstract Number: 1327
    Decreased CD3-CD16CD56+ Natural Killer Cell Counts Are Associated with Disease Activity in Children with Orbital Myositis
  • Abstract Number: 2733
    Decreased CXCR3+CCR4-CCR6+ CD4+ Effector Memory T Cells in Patients with Granulomatosis with Polyangiitis
  • Abstract Number: 670
    Decreased Disease Activity and Corticosteroid Usage and No Renal Flares during Belimumab Treatment in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 605
    Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naïve for TNF Blockers
  • Abstract Number: 637
    Decreased Inflammatory Dendritic Cells in Lupus-Prone Estrogen Receptor Alpha Knockout (ERαKO) Mice Correlate with Increased Survival
  • Abstract Number: 2677
    Decreased Levels of SRSF1 (Serin/Arginine-Rich Splicing Factor1) Induced Lower Levels of RasGRP1 in T Cells from Patients with Systemic Lupus Erythematosus
  • Abstract Number: 700
    Decreased Lung Diffusion Capacity in Asymptomatic Patients with Systemic Lupus Erythematosus Does Not Predict Future Lung Disease
  • Abstract Number: 650
    Decreased Severity of Pristane Induced Lupus in miR155 Deficient Mice
  • Abstract Number: 2094
    Deep Sequencing Reveals Differential RNA Expression during Malignant Transformation in Major Salivary Glands in a Mouse Model of Sjogren’s Syndrome
  • Abstract Number: 1949
    Defective PTEN Regulation and Function Contributes to B Cell Hyper-Responsiveness in Systemic Lupus Erythematosus
  • Abstract Number: 2087
    Defective Regulation of L1 Endogenous Retroelements in Primary Sjogren’s Syndrome and Systemic Lupus Erythematosus: Role of Methylating Enzymes
  • Abstract Number: 2724
    Deficiency of Ro52/TRIM21 in Different Subsets of Peripheral Blood Mononuclear Cells from Patients with Inflammatory Myopathies
  • Abstract Number: 1612
    Deficient Repair of DNA Double-Strand Breaks and Increased Apoptosis in Patients with Lupus Nephritis
  • Abstract Number: 556
    Defining Flare in Spondyloarthritis : Thresholds of Disease Activity Variations
  • Abstract Number: 2984
    Degenerative Changes of the Spine on MRI in Patients with Inflammatory Back Pain from the DESIR Cohort
  • Abstract Number: 1157
    Delay in Diagnosis from Onset of Symptoms By More Than One Year in 31% of Patients with Different Rheumatic Diseases in Australia
  • Abstract Number: 2794
    Deletion of the Inhibitory Receptor Motif, ITIM, on DC-STAMP Alters Osteoclast Differentiation and Function
  • Abstract Number: 333
    Deletion of the Prolactin Receptor Aggravates the Course of Antigen-Induced Arthritis
  • Abstract Number: 2327
    Delivering ESCAPE-Pain (Enabling Self-Management and Coping of Arthritic Pain through Exercise ) – an Online Guide for Healthcare Professionals
  • Abstract Number: 1422
    Demographic Differences in Health Related Information Technology Use Among Patients with Rheumatic Diseases
  • Abstract Number: 2292
    Demographic, Clinical and Treatment Characteristics of the Childhood Arthritis and Rheumatology Research Alliance Registry Systemic JIA Cohort
  • Abstract Number: 1503
    Demonstration of Functional Similarity Comparing Adalimumab to Biosimilar Candidate ABP 501
  • Abstract Number: 2264
    Denosumab for Long-Term Glucocorticoid Users Who Have Inadequate Response to the Bisphosphonates: A 12-Month Randomized Control Trial
  • Abstract Number: 1795
    Denosumab Restores Cortical Bone Loss at the Distal Radius Associated with Aging and Reduces Wrist Fracture Risk: Analyses from the Cross-over Group in the Extension of the Denosumab Pivotal Fracture Trial
  • Abstract Number: 195
    Dependence on Walking Aids and Patient-Reported Outcomes after Total Knee Arthroplasty
  • Abstract Number: 196
    Dependence on Walking Aids Is Associated with Pain and Mobility Limitation after Total Hip Arthroplasty
  • Abstract Number: 1742
    Depletion of Reactive Oxygen Species Biases T Cells to Proinflammatory Cytokine Production in Rheumatoid Arthritis
  • Abstract Number: 653
    Dermal Injury Promotes Nephritis Flare in Lupus-Prone NZM2328 Mice
  • Abstract Number: 113
    Dermatologic Rheumatism: Our Experience with a Multidisciplinary Dermatology/Rheumatology Clinic
  • Abstract Number: 1995
    Design and Implementation of a Clinical Teaching Tool for Approach to Children with Suspected New Rheumatologic Diagnosis
  • Abstract Number: 143
    Detailed Anatomical Distribution of Synovial Inflammation Revealed By Ultrasound in Patients with Blau Syndrome
  • Abstract Number: 2339
    Detecting Inflammation in Vivo Using Activatable Fluorescence Contrast Agents in Inflammatory Arthritis
  • Abstract Number: 4
    Detection of Anti-Beta2glycoprotein I Domain 1 Antibodies By an Automated Chemiluminescence Assay in a Cohort of 400 Clinically Characterized Consecutive Routine Samples
  • Abstract Number: 770
    Detection of Proteins in Lung Tissues of Patients with Systemic Sclerosis Using Tissue Microarrays
  • Abstract Number: 131
    Detection of Synovitis and Erosions with an Automated Ultrasound System: Data from a Prospective Cohort with Early and Established RA
  • Abstract Number: 2390
    Determinants and Impact of Early Initiation of Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
  • Abstract Number: 1857
    Determinants of Annual Healthcare Utilization and Overall Cost of Care in Individuals with Systemic Lupus Erythematosus in a Large Insurance Claims Database: Glucocorticoid Use
  • Abstract Number: 1925
    Determinants of Blood Hydroxychloroquine Concentration Variations in Systemic Lupus Erythematosus Patients
  • Abstract Number: 412
    Determinants of Radiological Progression in Rheumatoid Arthritis: Relationship with Serum Levels of OPG, RANKL and DKK-1
  • Abstract Number: L14
    Determination of Efficacy of Intra-Articular Infliximab Therapy in JIA Patients By 3D/4D Musculo-Skeletal Ultrasound
  • Abstract Number: 708
    Determining Risk Factors That Increase Hospitalizations in Patients with Systemic Lupus Erythematosis
  • Abstract Number: 2997
    Development and External Validation of a Five-Year Mortality Risk Stratification Tool for Early Diffuse Systemic Sclerosis Patients
  • Abstract Number: 357
    Development and Validation of a Diagnostic Bead-Based Multiplex Autoantibody Assay:Screening for Autoantibodies to Detect “Seronegative” Rheumatoid Arthritis
  • Abstract Number: 2716
    Development of a “Renal Crisis Prevention Card” As an Educational Tool Aimed at Improving Outcomes in High-Risk Patients with Systemic Sclerosis
  • Abstract Number: 771
    Development of a Bifluorescent Lineage Tracker Reporter Mouse Strain to Analyze the Phenotypic Conversion of Endothelial Cells into Myofibroblasts in Vivo. Application to Study the Synergistic Effects of Endothelin-1 on TGF-β1-Induced Endothelial-to-Mesenchymal Transition
  • Abstract Number: 2999
    Development of a Composite Index for Clinical Trials in Early Diffuse Cutaneous Systemic sclerosis—the Combined Response Index in Systemic Sclerosis
  • Abstract Number: 291
    Development of a Serious Game Designed for Children with Juvenile Idiopathic Arthritis
  • Abstract Number: 1304
    Development of an Index to Non-Invasively Quantify Lupus Nephritis Chronicity in Children
  • Abstract Number: 1939
    Development of Cell–Based Enzyme–Linked Immunosorbent Assay for the Quantification of Anti–M–type phospholipase–a–receptor Antibodies and Its Clinical Usefulness in Patients with Membranous Nephropathy
  • Abstract Number: 896
    Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey
  • Abstract Number: 2009
    Development of Multimedia Patient Education Tools (MM-PtET) for Osteoarthritis (OA), Osteoporosis (OP) and Rheumatoid Arthritis Patients (RA)
  • Abstract Number: 2831
    Development of New Radiographic Vertebral Fractures in Patients with Ankylosing Spondylitis during 4 Years of TNF-α Blocking Therapy: Results from the Glas Cohort
  • Abstract Number: 259
    Development of Pediatric Item Banks to Measure Pain Behavior in the Patient Reported Outcomes Measurement Information System
  • Abstract Number: 162
    Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises
  • Abstract Number: 2314
    Dexa Testing in Long-Term Steroid Use
  • Abstract Number: 1265
    Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase
  • Abstract Number: 2537
    Diagnostic Accuracies of Sialography and Salivary Ultrasonography in Sjogren’s Syndrome Patients: A Meta-Analysis
  • Abstract Number: 372
    Diagnostic Accuracy and Associated Costs of Rheumatoid Factor Testing in Primary Care: A Population-Based Cohort Study in Spain
  • Abstract Number: 2145
    Diagnostic Performance and Disease Activity Assessment By FDG-PET in Large-Vessel Vasculitis: A Systematic Literature Review and Meta-Analysis
  • Abstract Number: 1193
    Diagnostic value of Contrast-Enhanced MR-Angiography in diagnosing large Vessel Vasculitis
  • Abstract Number: 1463
    Dickkopf-1 Perpetuated Synovial Fibroblast Activation and Synovial Angiogenesis in Rheumatoid Arthritis
  • Abstract Number: 2594
    Differences in Localization and Activity of the Entheseal Involvement Between Non-Radiographic and Radiographic Axial Spondyloarthritis By the Ultrasound Assessment
  • Abstract Number: 197
    Differences in Total Hip Replacement Outcomes Based on Age
  • Abstract Number: 194
    Differences in Total Knee Replacement Outcomes Based on Age
  • Abstract Number: 2612
    Different Performance of the Major Disease Activity Measures ASDAS and Basdai in Patients with Axial Spondyloarthritis Treated with Non-Steroidal Anti-Inflammatory Agents – Results from a Prospective Study
  • Abstract Number: 992
    Differential Antigen-Presenting B-Cell Phenotype from Synovial Microenvironment of Rheumatoid Arthritis and Psoriatic Arthritis Patients
  • Abstract Number: 16
    Differential Assay Reactivity of IgA Anti-B2glycoprotein I Antibodies: Implications for Clinical Interpretation of Antiphospholipid Antibody Testing
  • Abstract Number: L8
    Differential DNA Methylation Associated with Lupus Nephritis
  • Abstract Number: 1884
    Differential DNA Methylation Associated with Rheumatoid Arthritis in Disease Discordant Monozygotic Twins
  • Abstract Number: 310
    Differential Expression of microRNA in Monocytes from Children with Systemic Juvenile Idiopathic Arthritis: Implications for Polarized Phenotype
  • Abstract Number: 1415
    Differential Gender Impact in the Quality of Life of Patients with Rheumatoid Arthritis. Comprehensive Study Including Clinical, Comorbidity and Psicho-Social Variables.
  • Abstract Number: 365
    Differential Relative Contribution of Individual Components on DAS28 over Time: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
  • Abstract Number: 600
    Differing Patterns of Axial Spondyloarthritis in Females and Males
  • Abstract Number: 445
    Differing Specificities of Anticitrullinated Peptide/Protein Antibodies in Palindromic Rheumatism and Rheumatoid Arthritis: A Case-Control Study
  • Abstract Number: 118
    Difficult to Treat Gouty Arthritis Associated with Poor Health Related Quality of Life and High Resource Utilization: Post- Hoc Analysis
  • Abstract Number: 2576
    Diffusing Weight Magnetic Resonance Imaging May Suggest the Treatment Strategy in Ankylosing Spondylitis
  • Abstract Number: 1171
    Diffusion–weighted Magnetic Resonance Imaging (MRI) of Wrist and Hands in Patients with Rheumatoid arthritis  –reproducibility and Correlation with Conventional MRI
  • Abstract Number: 576
    Dikkopf-1 (Dkk-1) Serum Levels in Axial Spondyloarthritis (axSpA) Are Related to Disease Duration
  • Abstract Number: 2048
    Disability in Discretionary Valued Life Activities and Self-Efficacy Explain a Significant Portion of RA Patients’ Global Assessments
  • Abstract Number: 959
    Discoid Lupus Onset and Decrease Risk of Renal Disease in Patients with Systemic Lupus Erythematosus: Data from a Large Latin American Cohort
  • Abstract Number: 495
    Discontinuation of Biologics in Patients with Rheumatoid Arthritis after Achieving Low-Activity Disease Status
  • Abstract Number: 269
    Discontinuation of Concomitant Medication for Enthesitis-Related Arthritis during 52 Weeks of Treatment with Adalimumab
  • Abstract Number: 1820
    Discordance of Hip Pain with Radiographic Hip Osteoarthritis: The Osteoarthritis Initiative
  • Abstract Number: 1491
    Discovery and Characterization of COVA322, a Clinical Stage Bispecific TNF/IL-17A Inhibitor for the Treatment of Inflammatory Diseases
  • Abstract Number: 1484
    Discovery of ARN-4079 – a Potent, Orally Available Dual Target Inhibitor of Janus Kinase 3 (JAK3) and Interleukin-2 Inducible T-Cell Kinase (ITK) for Rheumatoid Arthritis
  • Abstract Number: 543
    Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
  • Abstract Number: 1553
    Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
  • Abstract Number: 2755
    Disease Activity and Quality of Life in BEHÇET’S Disease: The Role of Patients Reportedoutcomes
  • Abstract Number: 2571
    Disease Activity and Risk of Cardiovascular Disease in Patients with Ankylosing Spondylitis with High and Low Body Mass Index
  • Abstract Number: 1395
    Disease Activity Is Associated with Insulin Resistance in Early Rheumatoid Arthritis
  • Abstract Number: 2578
    Disease Activity Is the Major Determinant of Quality of Life and Physical Function in Patients with Early Axial Spondyloarthritis. Results from the Esperanza Cohort.
  • Abstract Number: 396
    Disease Activity Scoring: Comparing Patient and Physician Global Assessment of Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 575
    Disease Activity Strongly Influences Work Productivity and Physical Health Related Quality of Life in Early Axial Spondyloarthritis: Data from the SPACE-Cohort
  • Abstract Number: 270
    Disease Burden Is Comparable in Children with Enthesitis-Related Arthritis and Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 1383
    Disease Characteristics and RA Development in Undifferentiated Arthritis: A 2-Year Follow-up Study of 413 Patients with Arthritis of Less Than 16 Weeks Duration
  • Abstract Number: 2598
    Disease Characteristics Associated with the Presence of Dactylitis in Patients with EARLY Spondyloarthritis: Results from Esperenza Cohort
  • Abstract Number: 1386
    Disease Flares during 10 Year Follow-up in Patients with Rheumatoid Arthritis Are Associated with Joint Damage Progression and Disability
  • Abstract Number: 1911
    Disease Modifying Anti-Rheumatic Drug Use and the Risk of Incident Hyperlipidemia in Patients with Early Rheumatoid Arthritis: A Retrospective Cohort Study
  • Abstract Number: 1636
    Disease Phenotype Is Associated with TH1, TH2 and TH17 Cytokines in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 945
    Disease Remission Reduces Risk of Heart Failure in Rheumatoid Arthritis Patients Independent of Treatment Strategy
  • Abstract Number: 1534
    Disease Severity and Treatment of Rheumatoid Arthritis: A Comparative Study Between Sudan and Sweden
  • Abstract Number: 1673
    Disease Specific Quality of Life in Patients with Lupus Nephritis
  • Abstract Number: 1518
    Disentangling the Effects of Tocilizumab on Neutrophil Survival and Function
  • Abstract Number: 1955
    Disparity in Internalisation of Monoclonal Antibodies Targeting B Cell Antigens and Regulation By Fc Gamma Receptor IIb: Implications for Targeted Therapy in SLE
  • Abstract Number: 2281
    Dissecting the Heterogeneity of  Macrophage Activation Syndrome
  • Abstract Number: 751
    Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis
  • Abstract Number: 1609
    Dissection of the Type I Interferon Response in Systemic Lupus Erythematosus : Serum IFNα Is Elevated in Lupus Nephritis and Correlates with IFN Score; IFNβ Is Elevated in Mucocutaneous Disease
  • Abstract Number: 657
    Distinct Contributions of C1q and C3 in Preventing Immunogenicity of Apoptotic Cells in Lupus
  • Abstract Number: 524
    Distinct Patterns of DNA Methylation in Labial Salivary Gland Tissue Based on Sjögren’s Syndrome Disease Status
  • Abstract Number: 438
    Distinct Profiles of Proinflammatory Macrophages in Rheumatoid Arthritis and Coronary Artery Disease
  • Abstract Number: 1541
    Distinct Regulation of T Helper Cell Differentiation By Biologic DMARD Therapy in Rheumatoid Arthritis
  • Abstract Number: 2977
    Distinct Serum Protein Signature and Novel Biomarkers of primary Sjogren’s Syndrome Revealed by comprehensive High-Throughput Proteomic Analysis
  • Abstract Number: 2816
    Distinctive DNA Methylome Signatures in Early Rheumatoid Arthritis (RA) Synoviocytes Compared with Longstanding (RA) and Other Inflammatory Arthritides
  • Abstract Number: 1270
    Distinctive Muscle Histopathological Features of Anti-Synthetase Syndrome
  • Abstract Number: 757
    Distinctive Patterns of Telomere Shortening and Apoptosis in Limited and Diffuse cutaneous  Systemic Sclerosis
  • Abstract Number: 381
    Distribution and Clinical Significance of Anti-Heterogenic Nuclear Ribonucleoprotein A2 Antibody in Connective Tissue Diseases
  • Abstract Number: 185
    Distribution of Haemochromatosis Arthropathy. High Ankle and Mid Foot Prevalence; A Diagnostic Clue ?
  • Abstract Number: 2388
    DMARD Use after an Initial Acute MI Is Associated with Reduced Risk of a Recurrent Event and Mortality
  • Abstract Number: 2680
    DNA Hydroxymethylation Changes in CD4+T Cells from Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2448
    DNA Methylation Analysis of Lymph Node Stromal Cells of Rheumatoid Arthritis Patients
  • Abstract Number: 881
    DNA Methylation Analysis of the Temporal Artery Microenvironment Reveals a Robust T Cell Signature and Suggests a Role for TNF-α in Giant Cell Arteritis
  • Abstract Number: 2446
    DNA Methylation Profiles That Distinguish Rheumatoid Arthritis from Osteoarthritis in Fibroblast-like Synoviocytes Can be Detected in Immune Cells from Peripheral Blood
  • Abstract Number: 1813
    DNA Sensors Regulate Inflammation in a Model of Autoimmune Arthritis
  • Abstract Number: 594
    Do Bone Marrow Edema Lesions in the Sacroiliac Joint Change into Fatty Lesions over a 1-Year Period in Patients with Axial Spondyloarthritis or Possible Spondyloarthritis
  • Abstract Number: 574
    Do Extra-Articular Manifestations Influence Outcome in Ankylosing Spondylitis? a 12 Year Follow-up Study
  • Abstract Number: 2060
    Do Fibromyalgia Patients Have a Distinct Sleep Signature?
  • Abstract Number: 1467
    Do G-CSF and Neutrophils Contribute to the Pathophysiology of Rheumatoid Arthritis?
  • Abstract Number: 2018
    Do Mediterranean or Vegetarian Diets Influence Risk of Rheumatoid Arthritis?
  • Abstract Number: 2599
    Do Patients Diagnosed As Axial Spondyloarthritis (AxSpA) Who Have Primary Inefficacy to Anti-TNF Really Have AxSpA? a Five-Year Follow-up Study of 27 Patients with Primary Inefficacy to Anti-TNF
  • Abstract Number: 1182
    Do Patients with Active RA Also Have Inflamed Atherosclerotic Plaques on PET-MRI?
  • Abstract Number: 2574
    Do Patients with Axial Spondyloarthritis (AxSpA) Perform Enough Physical Activity? a Cross-Sectional Study of 207 Patients
  • Abstract Number: 491
    Do Patients with Congestive Heart Failure Treated with Biologics for RA Have a Lower Risk of Fatal Outcome of Serious Infections?
  • Abstract Number: 2940
    Do Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Respond Similarly Well to Nsaids? – a Prospective Study Including Magnetic Resonance Imaging
  • Abstract Number: 2416
    Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain?  Implications for Clinical Practice
  • Abstract Number: 2554
    Do TNF Alpha Inhibitors Have an NSAID Sparing Effect in Real Life in Early Axial Spa? Results from the DESIR Cohort
  • Abstract Number: 132
    Do Ultrasound (PDUS) and DAS28 Measure Different Aspects of Disease Activity? Analyses from the First Prospective International Phase IIIb Study of PDUS Response in Abatacept-Treated Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 2608
    Do You Assess Gastro-Intestinal Auto-Antibodies and Symptoms in Patients with Spondyloarthritis?
  • Abstract Number: 351
    Doctor, Will My Fatigue be Better If I’m in Remission? an Exploratory Analysis of 1284 Rheumatoid Arthritis (RA) Patients Indicates Fatigue Is the Only Aspect of Patient-Perceived Impact to Remain Significant in ACR/EULAR Boolean Remission
  • Abstract Number: 2890
    Does a Family History of RA Influence the Clinical Presentation and Treatment Response in RA?
  • Abstract Number: 926
    Does a Family History of Total Knee Replacement for Knee Osteoarthritis Influence Knee Pain and Structural Progression? a Prospective Longitudinal Cohort Study
  • Abstract Number: 503
    Does a Higher Dose of Folic Acid Reduce Adverse Effects of Methotrexate in Rheumatoid Arthritis? a Randomized Controlled Trial
  • Abstract Number: 2273
    Does a Standardized Multidisciplinary Approach Improve Outcomes for Children with NMDA Receptor Antibody Encephalitis? : A Preliminary Assessment of a Single Center Experience
  • Abstract Number: 239
    Does Adjusting BMI for Lean Mass Deficits Affect Calculated Fracture Risk Using FRAX in Rheumatoid Arthritis?
  • Abstract Number: 1657
    Does Advanced Age Influence the Type of Renal Injury and the Prognosis of Lupus Nephritis?
  • Abstract Number: 1309
    Does Anti-C1q Antibody Have Diagnostic and Prognostic Roles in Childhood – Onset Systemic Lupus Erythematosus?
  • Abstract Number: 1092
    Does Arthritis Status Predict Starting or Stopping Work over a 2-Year Period?
  • Abstract Number: 2492
    Does Body Mass Index Impact Long-Term Retention with Abatacept in Patients with RA Who Have Received at Least One Prior Biologic Agent? 2-Year Results from a Real-World, International, Prospective Study
  • Abstract Number: 2913
    Does Corticosteroid Therapy at Disease Onset Influence Disease Progression of RA? Results from the Swiss Prospective Observational Cohort
  • Abstract Number: 2225
    Does Previous Corticosteroid Treatment Affect the Inflammatory Infiltrate Found in Polymyositis Muscle Biopsies?
  • Abstract Number: 1993
    Does Psychological Safety Impact Learning Environments Among Rheumatology Fellows: Findings from Veterans Affairs Learners’ Perception Survey
  • Abstract Number: 3014
    Does the Order or Amount of Risk-Benefit Information Presented Influence patients’ Perceived Value of a Proposed New Medication?
  • Abstract Number: 1480
    Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach
  • Abstract Number: 515
    Dosing of Intravenous Tocilizumab in a Real-World Setting—Analyses from a US RA Registry
  • Abstract Number: 370
    Double Positivity of RA Serologies More Prevalent Yet Associated with Clinical Response in Ethnic Minority Patients with Rheumatoid Arthritis
  • Abstract Number: 530
    Downregulation of Microrna-183 in Sjogren’s Syndrome Minor Salivary Glands. Implications in Control of Ezrin Expression and Salivary Gland Function
  • Abstract Number: 2450
    Downregulation of Mirna-196a and Its Downstream HOXC8 Target Gene in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 285
    Drug Safety in Treatment of Juvenile Idiopathic Arthritis (JIA): Biologic Therapy Compared with MTX
  • Abstract Number: 2776
    Drug-Associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center
  • Abstract Number: 1686
    DUAL Energy Computed Tomography for the Evaluation of Calcinosis in Systemic Sclerosis
  • Abstract Number: 2148
    Dual Energy CT Scanning: Variable Sensitivity for Gout in Non-Tophaceous and Tophaceous Disease and in Individual Erosions
  • Abstract Number: 2820
    Dual Role for B Cells in Promoting Bone Erosion in Rheumatoid Arthritis Via Effects on Osteoclast and Osteoblast Differentiation
  • Abstract Number: 2380
    Durability of First Biologic Is Not Influenced By Initial/Early DAS28
  • Abstract Number: 219
    DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort
  • Abstract Number: 1180
    Dynamic Magnetic Resonance Imaging in the Assessment of the Response to Certolizumab Pegol in Rheumatoid Arthritis Patients: Results from a Phase IIIb Randomized Study
  • Abstract Number: 661
    Dysfunction of Glycosphingolipid Metabolism in Lupus Nephritis
  • Abstract Number: 1040
    Dysregulated Serum Interleukin 16 Concentration Associated with Clinical Disease Activity in Patients with Rheumatoid Arthritis Is Efficiently Corrected By Immunological Intervention
  • Abstract Number: 1957
    Dysregulation of CC Chemokines at Microvascular Endothelial Cells of Blood and Lymphatic Vessels Under Inflammatory Conditions
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences